PAXLOVID under the microscope: new study confirms safety in thousands
NCT ID NCT05263908
First seen Nov 01, 2025 · Last updated May 14, 2026 · Updated 32 times
Summary
This study checked how safe and effective the COVID-19 medicine PAXLOVID is in real-world use. Over 3,300 people aged 12 and older who took PAXLOVID were watched for 28 days. Researchers tracked side effects and whether the infection got worse. The goal was to make sure the drug works well outside of a controlled trial.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SARS-COV-2 INFECTION are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Pfizer Local County
Tokyo, 1518589, Japan
Conditions
Explore the condition pages connected to this study.